切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2016, Vol. 09 ›› Issue (05) : 315 -320. doi: 10.3877/cma.j.issn.1674-6880.2016.05.006

所属专题: 文献

论著

血必净对脓毒性急性肾损伤大鼠肾小管细胞凋亡和相关蛋白表达的影响
孙雪东1,(), 严一核1, 刘芳2, 褚韦韦1, 张亦婷1, 应利君1   
  1. 1. 312000 浙江绍兴,绍兴市人民医院重症医学科
    2. 312000 浙江绍兴,绍兴市人民医院病理科
  • 收稿日期:2016-06-05 出版日期:2016-10-01
  • 通信作者: 孙雪东
  • 基金资助:
    浙江省绍兴市科技计划项目(2014B70066)

Effect of xuebijing injection on tubular apoptosis and related proteins expression in rat model of sepsis-induced acute kidney injury

Xuedong Sun1,(), Yihe Yan1, Fang Liu2, Weiwei Chu1, Yiting Zhang1, Lijun Ying1   

  1. 1. Department of Intensive Medicine, Shaoxing People's Hospital, Shaoxing 312000, China
    2. Department of Pathology, Shaoxing People's Hospital, Shaoxing 312000, China
  • Received:2016-06-05 Published:2016-10-01
  • Corresponding author: Xuedong Sun
  • About author:
    Corresponding author: Sun Xuedong, Email:
引用本文:

孙雪东, 严一核, 刘芳, 褚韦韦, 张亦婷, 应利君. 血必净对脓毒性急性肾损伤大鼠肾小管细胞凋亡和相关蛋白表达的影响[J]. 中华危重症医学杂志(电子版), 2016, 09(05): 315-320.

Xuedong Sun, Yihe Yan, Fang Liu, Weiwei Chu, Yiting Zhang, Lijun Ying. Effect of xuebijing injection on tubular apoptosis and related proteins expression in rat model of sepsis-induced acute kidney injury[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2016, 09(05): 315-320.

目的

探讨早期应用血必净对脓毒性急性肾损伤大鼠肾小管细胞凋亡,及相关蛋白B细胞淋巴瘤2(Bcl-2)和Bcl-2相关X蛋白(Bax)表达的影响。

方法

54只雄性大鼠分为假手术组(Sham组)、脓毒症组(CLP组)、血必净组(CLP + XBJ组)三组,每组18只;以术后12、24和48 h作为时间观察点,将各组再分为3个亚组,每组6只。在各时间点检测大鼠的肌酐清除率(CrCl)、肾脏血流灌注量,并留取肾脏组织观察病理学变化,计算肾小管损伤评分,采用原位末端标记(TUNEL)法并通过计算积分光密度值(IOD)测定肾小管凋亡细胞,采用Western-blotting法测定肾脏髓质Bcl-2、Bax的变化。

结果

三组大鼠的CrCl和肾脏血流灌注量在术后各时间点差异均有统计学意义(F = 6.405、18.821,P < 0.05);且CLP + XBJ组在术后48 h时CrCl和肾脏血流灌注量明显高于CLP组[(2.1 ± 0.5)ml/min/100 g vs.(1.1 ± 0.3)ml/min/100 g,(159 ± 38)BPU vs.(79 ± 32)BPU;P均< 0.05]。三组大鼠肾小管损伤评分比较,不同时间点差异存在统计学意义(F = 5.461,P < 0.05);且CLP + XBJ组与CLP组比较,24、48 h时评分均有显著下降[(1.6 ± 0.5)vs.(2.8 ± 0.8),(1.8 ± 0.8)vs.(3.6 ± 0.6);P均< 0.05]。三组大鼠各时间点凋亡细胞IOD值,差异存在统计学意义(F = 7.259,P < 0.05);CLP + XBJ组各时间点的IOD值均明显小于CLP组[(26.6 ± 6.9)vs.(34.4 ± 5.0),(38.2 ± 5.3)vs.(48.0 ± 5.8),(37.6 ± 2.2)vs.(53.8 ± 6.7);P均< 0.05]。同时,CLP + XBJ组能升高大鼠肾脏髓质Bcl-2的表达,抑制Bax的表达,维持Bcl-2/Bax的平衡,24、48 h时其Bcl-2[(1.30 ± 0.09)vs.(0.76 ± 0.09),(2.12 ± 0.38)vs.(0.51 ± 0.07);P均< 0.05]和Bax[(1.19 ± 0.37)vs.(1.95 ± 0.90),(1.48 ± 0.15)vs.(2.69 ± 0.39);P均< 0.05]的表达水平与脓毒症组相比差异均有统计学意义。

结论

早期应用血必净可以减少肾小管细胞在脓毒症进程中的凋亡,改善脓毒性急性肾损伤大鼠肾脏的病理学改变,维持Bcl-2/Bax的平衡,减轻脓毒症导致的肾功能损害。

Objective

To investigate the effect of early application of xuebijing in rat model of sepsis-induced acute kidney injury by observing tubular apoptosis, B cell lymphoma 2 (Bcl-2) and Bcl-2 associated X protein (Bax) expressions.

Methods

Fifty-four male SD rats were randomly divided into three groups: Sham group (n = 18), cecal ligation and puncture (CLP) group (n = 18), and xuebijing (CLP + XBJ) group (n = 18). After rat model establishment, 12, 24, 48 h were regarded as observation time points, and each group was accordingly divided into 3 subgroups (6 rats per subgroup). Creatine clearance (CrCl), renal blood perfusion unit, renal pathological changes and renal tubular injury score were measured; renal tubular cell apoptosis was determined by terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) method and integrated optical density (IOD) was calculated. The expressions of Bcl-2 and Bax were detected by Western-blotting.

Results

The CrCl and renal blood perfusion unit in all three groups had significant differences at each time point (F = 6.405, 18.821; P < 0.05). The CrCl and renal blood perfusion unit in the CLP + XBJ group were significantly higher than that in the CLP group [(2.1 ± 0.5) ml/min/100 g vs. (1.1 ± 0.3) ml/min/100 g, (159 ± 38) BPU vs. (79 ± 32) BPU; all P < 0.05]. The renal tubular damage scores in all three groups had significant differences at each time point (F = 5.461, P < 0.05). Tubular damage scores decreased significantly in the CLP + XBJ group compared with the CLP group at 24, 48 h [(1.6 ± 0.5) vs. (2.8 ± 0.8), (1.8 ± 0.8) vs. (3.6 ± 0.6); all P < 0.05]. The IOD had a significant difference in all three groups at each time point (F = 7.259, P < 0.05). In addition, the IOD in the CLP + XBJ group was much lower than that in the CLP group at each time point [(26.6 ± 6.9) vs. (34.4 ± 5.0), (38.2 ± 5.3) vs. (48.0 ± 5.8), (37.6 ± 2.2) vs. (53.8 ± 6.7); all P < 0.05]. Meanwhile, xuebijing injection could increase Bcl-2 expression, inhibit Bax expression, and keep balance of Bcl-2/Bax ratio. There were significant differences of Bcl-2 [(1.30 ± 0.09) vs. (0.76 ± 0.09), (2.12 ± 0.38) vs. (0.51 ± 0.07); all P < 0.05] and Bax [(1.19 ± 0.37) vs. (1.95 ± 0.90), (1.48 ± 0.15) vs. (2.69 ± 0.39); all P < 0.05] in the CLP + XBJ group compared with the CLP group at 24 and 48 h.

Conclusion

Early application of xuebijing might improve renal dysfunction and the pathological changes, reduce the tubular cell apoptosis, keep balance of Bcl-2/Bax ratio and relieve renal impairment in rat model of sepsis-induced acute kidney injury.

表1 三组大鼠各时间点CrCl和肾脏血流灌注量的比较(±s
图1 各组大鼠肾脏组织不同时间点病理染色图。注:a~c图为Sham组;d~f图为CLP组,24、48 h可见明显的肾小管退化、空泡变和坏死,以及管型或透明管型细胞并伴有大量单核细胞浸润;g~i图为CLP + XBJ组,24、48 h可见肾小管空泡变性减少,单核细胞浸润未见明显增加;Sham组:假手术组;CLP组:脓毒症组;CLP + XBJ组:血必净组(HE染色× 400)
表2 三组大鼠各时间点肾小管损伤评分(分,±s
图2 各组大鼠肾脏免疫荧光染色图。注:a~c图为Sham组;d~f图为CLP组,24 h后可见凋亡细胞逐步增加,48 h后显示大量簇状、成堆凋亡细胞;g~i图为CLP + XBJ组,24、48 h凋亡细胞稍增加;Sham组:假手术组;CLP组:脓毒症组;CLP + XBJ组:血必净组(TUNEL染色× 400)
表3 三组大鼠各时间点肾小管凋亡细胞的IOD比较(±s
表4 三组大鼠肾脏髓质各时间点Bcl-2的相对表达水平(±s
表5 三组大鼠肾脏髓质各时间点Bax的相对表达水平(±s
1
Wan L,Bagshaw SM,Langenberg C, et al. Pathoph-ysiology of septic acute kidney injury: what do we really know?[J]. Crit Care Med, 2008, 36(4 Suppl): S198-S203.
2
Holthoff JH,Wang Z,Seely KA, et al. Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury[J]. Kidney Int, 2012, 81(4): 370-378.
3
程星,曹丽萍,乔佑杰, 等. 腹腔注射血必净对脓毒症急性肾损伤大鼠肾功能的影响及机制探讨[J]. 山东医药, 2015, 5(23):28-30.
4
Rittirsch D,Huber-Lang MS,Flierl MA, et al. Immunodesign of experimental sepsis by cecal ligation and puncture[J]. Nat Protoc, 2009, 4(1): 31-36.
5
Langenberg C,Bagshaw SM,May CN, et al. The histopathology of septic acute kidney injury: a systematic review[J]. Crit Care, 2008, 12(2): R38-R45.
6
臧芝栋,严洁. 以提高肾脏病整体预后工作组诊断标准分析脓毒症相关急性肾损伤患者的临床特点[J]. 中华内科杂志, 2013, 52(4):299-304.
7
Choi HM,Jo SK,Kim SH, et al. Glucocorticoids attenuate septic acute kidney injury[J]. Biochem Biophys Res Commun, 2013, 435(4): 678-684.
8
Pathak E,MacMillan-Crow LA,Mayeux PR. Role of mitochondrial oxidants in an in vitro model of sepsis-induced renal injury[J]. J Pharmacol Exp Ther, 2012, 340(1): 192-201.
9
Tran M,Tam D,Bardia A, et al. PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice[J]. J Clin Invest, 2011, 121(10): 4003-14.
10
Parikh SM. Therapeutic targeting of the mitochondrial dysfunction in septic acute kidney injury [J]. Curr Opin Crit Care, 2013, 19(6): 554-559.
11
Yao W,Hu Q,Ma Y, et al. Human adipose-derived mesenchymal stem cells repair cisplatin-induced acute kidney injury through antiapoptotic pathways[J]. Exp Ther Med, 2015, 10(2): 468-476.
12
Chen LW,Chen W,Hu ZQ, et al. Protective effects of growth arrest-specific protein 6 (Gas6) on sepsis-induced acute kidney injury[J]. Inflammation, 2016, 39(2): 575-582.
13
王茹,张俊录,李月红, 等. 细胞凋亡及Bcl-2和Bax基因表达在脓毒症大鼠肾脏损伤中的作用[J]. 实用医学杂志, 2011, 27(7):1164-1166.
14
陈敏华,孙仁华,李茜. 脓毒症伴急性肾损伤患者连续性肾脏替代治疗时机的探讨[J/CD]. 中华危重症医学杂志:电子版, 2016, 9(3):149-153.
15
Pickkers P,Heemskerk S,Schouten J, et al. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial[J]. Critical Care, 2011, 16(1): R14
16
Li N,Xie H,Li L, et al. Effects of honokiol on sepsis-induced acute kidney injury in an experimental model of sepsis in rats[J]. Inflammation, 2014, 37(4): 1191-1199.
17
孟东亮,邢海波,茅尧生, 等. 中性粒细胞明胶酶相关脂质运载蛋白对脓毒症继发急性肾损伤患者的早期预测价值[J/CD]. 中华危重症医学杂志:电子版, 2015, 8(4):224-229.
18
王永明,乔佑杰,李家瑞, 等. 血必净对脓毒症大鼠巨噬细胞移动抑制因子和急性肾损伤的干预效果[J]. 天津医药, 2014, 42(10):988-991.
[1] 孔莹莹, 谢璐涛, 卢晓驰, 徐杰丰, 周光居, 张茂. 丁酸钠对猪心脏骤停复苏后心脑损伤的保护作用及机制研究[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 355-362.
[2] 韩圣瑾, 周正武, 翁云龙, 黄鑫. 碳酸氢钠林格液联合连续性肾脏替代疗法对创伤合并急性肾损伤患者炎症水平及肾功能的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 376-381.
[3] 张秋彬, 张楠, 林清婷, 徐军, 朱华栋, 姜辉. 急性胰腺炎合并急性肾损伤患者的预后评估[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 382-389.
[4] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[5] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[6] 窦上文, 邓欢, 刘邦锋, 岳高远志, 朱华财, 刘永达. 术前复查尿培养在预测微通道经皮肾镜取石术相关感染并发症中的作用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 361-366.
[7] 刘硕儒, 王功炜, 张斌, 李书豪, 胡成. 新型溶瘤病毒M1激活内质网应激致前列腺癌细胞凋亡的机制[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 388-393.
[8] 李青霖, 宋仁杰, 周飞虎. 一种重型劳力性热射病相关急性肾损伤小鼠模型的建立与探讨[J]. 中华肾病研究电子杂志, 2023, 12(05): 265-270.
[9] 任加发, 邬步云, 邢昌赢, 毛慧娟. 2022年急性肾损伤领域基础与临床研究进展[J]. 中华肾病研究电子杂志, 2023, 12(05): 276-281.
[10] 李金璞, 饶向荣. 抗病毒药物和急性肾损伤[J]. 中华肾病研究电子杂志, 2023, 12(05): 287-290.
[11] 于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[12] 易成, 韦伟, 赵宇亮. 急性肾脏病的概念沿革[J]. 中华临床医师杂志(电子版), 2023, 17(08): 906-910.
[13] 谭睿, 王晶, 於江泉, 郑瑞强. 脓毒症中高密度脂蛋白、载脂蛋白A-I和血清淀粉样蛋白A的作用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(06): 749-753.
[14] 蔡荇, 郑瑞强. 肝素结合蛋白在脓毒症中的应用及研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(04): 487-490.
[15] 邱甜, 杨苗娟, 胡波, 郭毅, 何奕涛. 亚低温治疗脑梗死机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 518-521.
阅读次数
全文


摘要